View Post

Chico’s FAS, Inc. Announces 14th Annual Partnership with Living Beyond Breast Cancer

In In The News, Uncategorized by Barbara Jacoby

Specialty Retailer Raises Funds to Support Women and Families Chico’s FAS, Inc. (NYSE: CHS) and its family of brands, Chico’s, White House Black Market and Soma, announce its 14th annual partnership with Living Beyond Breast Cancer, a national nonprofit organization that connects people with trusted breast cancer information and a community of support. “Chico’s FAS is committed to women’s health …

View Post

Register for Cancer Research Institute FREE Immunotherapy Patient Summits

In In The News, Uncategorized by Barbara Jacoby

Cancer Research Institute Immunotherapy Patient Summits are free half-day Saturday events that provide a forum for patients, caregivers, and advocates to meet together along with scientific and healthcare experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers. In 2018, the Immunotherapy Patient Summit are upcoming to New York City, San Diego, …

View Post

PRMA Plastic Surgery Offering Breast Reconstruction Follow-Up Services for Hurricane Harvey Evacuees

In In The News, Uncategorized by Barbara Jacoby

The surgeons of PRMA Plastic Surgery are honored to offer breast reconstruction surgery follow up care for patients who have been displaced by the recent storms until patients are able to resume care with their local physician. PRMA Plastic Surgery is offering follow up care after breast reconstruction surgery for patients displaced by Hurricane Harvey at no charge. “Our goal …

View Post

Acupuncture might ease hot flashes for breast cancer patients

In In The News, Uncategorized by Barbara Jacoby

By: Alan Mozes, HealthDay News From: upi.com Acupuncture can help alleviate the often-debilitating hot flashes that afflict many breast cancer patients, new Italian research says. Noting that hot flashes are a fact of life for many women with breast cancer, the investigators found that pairing lifestyle advice with weekly acupuncture sessions dramatically improved the women’s quality of life. “Acupuncture together …

View Post

Oncoceutics Begins Fifth Clinical Trial for ONC201

In Uncategorized by Barbara Jacoby

Oncoceutics, Inc. announced that patient enrollment has commenced for a clinical trial at the Massachusetts General Hospital (MGH) of the company’s lead compound, ONC201, in glioblastoma multiforme (GBM). The trial, identified as NCT02525692 on www.clinicaltrials.gov, is entitled “Oral ONC201 in Adult Recurrent Glioblastoma”. The Phase II trial will investigate the use of single agent ONC201 in adult patients with glioblastoma …

View Post

Cancer vaccines enter clinical trials

In In The News, Uncategorized by Barbara Jacoby

By Blythe Bernhard From: stltoday.com Is the best treatment for cancer already inside of us? Research is underway at Washington University to test a new approach to cancer treatment. Beyond traditional therapies like surgery, chemotherapy and radiation, scientists want to know if the human body’s own immune system can attack tumors. They’re testing personalized vaccines designed to target deadly cancer …

View Post

Breast Cancer: New Test Determines If Disease Will Spread To Brain

In In The News, Uncategorized by Barbara Jacoby

By: Kathleen Lees From: scienceworldreport.com A new test may help identify if particularly aggressive forms of breast cancer are at risk of spreading to the brain. The findings are published in the journal npj Breast Cancer. Findings revealed that participants who tested positive for the gene known as alpha beta (αB)-crystallin were up to three times more likely to have …

View Post

EU Recommends Approval of Roche’s Pre-Surgery Breast Cancer Treatment

In In The News, Uncategorized by Barbara Jacoby

From: dddmag.com Roche announced that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approves the use of Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy for the neoadjuvant treatment (use before surgery) of adult patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrence. The EU filing was …